n-vinyl-2-pyrrolidinone has been researched along with Antibody Deficiency Syndrome in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abramenko, TV; Mustafaev, MI; Norimov, ASh; Romanova, RIu | 1 |
| Evstratova, EF; Provotorov, VM; Zemskov, AM; Zemskov, VM | 1 |
| Braley-Mullen, H; Van Buskirk, AM | 2 |
| Akbar, AN; de Sousa, M; Fitzgerald-Bocarsly, PA; Giardina, PJ; Grady, RW; Hilgartner, MW | 1 |
| Papko, AG; Shmelev, EI | 1 |
6 other study(ies) available for n-vinyl-2-pyrrolidinone and Antibody Deficiency Syndrome
| Article | Year |
|---|---|
[Polymer-metal complexes of the Mycobacterium protein antigen prevent the dissemination of postvaccinal infection in the T-deficiency state].
Topics: Animals; Antigens, Bacterial; BCG Vaccine; Copper; Drug Combinations; Drug Evaluation, Preclinical; Immunization; Immunologic Deficiency Syndromes; Mice; Mice, Inbred CBA; Mycobacterium tuberculosis; Pyrrolidinones; T-Lymphocytes; Thymectomy; Tuberculosis | 1991 |
[Comparative effectiveness of immunomodulators in the therapy of rheumatic heart defects].
Topics: Adjuvants, Immunologic; Adult; Drug Evaluation; Drug Therapy, Combination; Humans; Immunologic Deficiency Syndromes; Levamisole; Middle Aged; Nucleic Acids; Povidone; Rheumatic Heart Disease; T-Lymphocytes | 1984 |
Characterization of helper T cells induced by the type 2 antigen polyvinylpyrrolidone.
Topics: Animals; Antibody Formation; Antigens, Surface; B-Lymphocytes; Immunization, Passive; Immunoglobulin G; Immunoglobulin Heavy Chains; Immunologic Deficiency Syndromes; Immunologic Memory; Lymphocyte Activation; Lymphocyte Cooperation; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Phenotype; Povidone; T-Lymphocytes; T-Lymphocytes, Helper-Inducer | 1987 |
Suppression of IgG memory responses by T cells activated with the type 2 antigen polyvinylpyrrolidone (PVP).
Topics: Animals; Antigens, Differentiation, T-Lymphocyte; Antigens, Ly; Antigens, Surface; Antigens, T-Independent; Histocompatibility Antigens Class II; Immunoglobulin Allotypes; Immunoglobulin G; Immunologic Deficiency Syndromes; Immunologic Memory; Immunosuppression Therapy; Lymphocyte Activation; Mice; Mice, Mutant Strains; Povidone; T-Lymphocytes; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory | 1987 |
Decreased natural killer activity in thalassemia major: a possible consequence of iron overload.
Topics: Cell Separation; Centrifugation, Density Gradient; Cytotoxicity, Immunologic; Humans; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Iron; Iron Chelating Agents; Killer Cells, Natural; Povidone; Silicon Dioxide; Thalassemia; Transfusion Reaction | 1986 |
[Detoxication with hemodes--a method of preventing secondary immunologic deficiency in patients with acute pneumonia].
Topics: Acute Disease; Adjuvants, Immunologic; Bronchopneumonia; Humans; Immunologic Deficiency Syndromes; Povidone; Rosette Formation; T-Lymphocytes; Toxemia | 1986 |